ETFs Shenyang Xingqi Pharmaceutical Co.,Ltd.

300573

CNE100002DV1

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2024-09-11			5-day change	1st Jan Change
76.28 ^CNY	-0.69%		-5.32%	-41.43%

08-29	Shenyang Xingqi Pharmaceutical Co.,Ltd. Proposes Profit Distribution for First Half of 2024	CI
08-28	Shenyang Xingqi Pharmaceutical Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI

ETFs positioned on Shenyang Xingqi Pharmaceutical Co.,Ltd.

Name	Weight	AuM	1st Jan change	Investor Rating
VANECK CHINA GROWTH LEADERS ETF - USD	0.43%	12 M€	-16.71%	-

SHENYANG XINGQI PHARMACEUTICAL CO., LTD. is a China-based company principally engaged in the research, development, manufacture and distribution of ophthalmic drugs. The Companyâs main products are ophthalmic prescription drugs, including corneal repairing drugs, anti-bacteria drugs, artificial tears, anti-inflammation drugs, anti-allergic drugs, as well as anti-hyperemia & fatigue relief drugs and others. The Company mainly distributes its products within domestic market.

Employees

1,995

Sector

Pharmaceuticals

Calendar

2024-10-23 - Q3 2024 Earnings Release (Projected)

More about the company